Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Neptune Wellness Solutions (NEPT) will report the company’s financial results from the third quarter of fiscal 2020, before markets open on February 13th.
  • After the financial results are released, Neptune will host a conference call to discuss the financial results from October, November, and December of 2019.
  • The conference call will take place at 8:30am (EST) on February 13th 2020.
  • A replay of the call will be available online for a month.
  • Neptune’s share price is down 1.17 per cent, with shares trading at $3.37 apiece.

Before markets open on February 13th, biotechnology company Neptune Wellness (NEPT) will report the company’s financial results from fiscal 2020’s third quarter.

After the results are released, Neptune will hold a conference call, to discuss results for the 3 month period which ended on December 31st 2019.

The conference call (ID 8708188) will take place on Thursday, February 13th 2020, at 8:30am Eastern Standard Time.

For investors from Canada and the United States, the call number will be 1 (888) 231-8191. For all international investors, the call number will be 1 (647) 427-7450.

A replay of the call will be available online on Neptune’s website, under Investor Events and Presentations. The replay will be accessible until March 13th 2020.

Neptune’s share price is down 1.17 per cent, with shares trading at $3.37 apiece.

More From The Market Herald

" WELL Health NCIB suggests undervaluation

WELL Health has entered into an automatic share purchase plan to facilitate share repurchases.

" Best biotech stocks to buy in 2023

Innovation continues to drive the broader healthcare market, and the best biotech stocks are at the forefront of new developments and therapies to
Lifeist

" Lifeist to acquire the fast-growing ‘Zest’ brand

Lifeist Wellness (TSXV:LFST) has signed a share purchase agreement to acquire the Zest brand.

" Advancing environmental work at the Frances Creek barium project

Voyageur Pharmaceuticals (TSXV:VM) has finished environmental and geotechnical field work at its Frances Creek project site.